Dihydropteridine reductase deficiency

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Dihydropteridine reductase deficiency.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

Kuvan

BioMarin Pharmaceutical, Inc.

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Kuvan

(sapropterin)Orphan drugstandard

BioMarin Pharmaceutical, Inc.

12.1 Mechanism of Action KUVAN is a synthetic form of BH4, the cofactor for the enzyme phenylalanine hydroxylase (PAH). PAH hydroxylates Phe through a...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Dihydropteridine reductase deficiency.
Search all trials →
Search clinical trials for Dihydropteridine reductase deficiency

Recent News & Research

No recent news articles indexed yet for Dihydropteridine reductase deficiency.
Search PubMed for Dihydropteridine reductase deficiency

Browse all Dihydropteridine reductase deficiency news →

Specialist Network

Top 6 by expertise

View all Dihydropteridine reductase deficiency specialists →

Quick Actions